Literature DB >> 25427213

Discovery of a low order drug-cell response surface for applications in personalized medicine.

Xianting Ding1, Wenjia Liu, Andrea Weiss, Yiyang Li, Ieong Wong, Arjan W Griffioen, Hubert van den Bergh, Hongquan Xu, Patrycja Nowak-Sliwinska, Chih-Ming Ho.   

Abstract

The cell is a complex system involving numerous components, which may often interact in a non-linear dynamic manner. Diseases at the cellular level are thus likely to involve multiple cellular constituents and pathways. As some drugs, or drug combinations, may act synergistically on these multiple pathways, they might be more effective than the respective single target agents. Optimizing a drug mixture for a given disease in a particular patient is particularly challenging due to both the difficulty in the selection of the drug mixture components to start out with, and the all-important doses of these drugs to be applied. For n concentrations of m drugs, in principle, n(m) combinations will have to be tested. As this may lead to a costly and time-consuming investigation for each individual patient, we have developed a Feedback System Control (FSC) technique which can rapidly select the optimal drug-dose combination from the often millions of possible combinations. By testing this FSC technique in a number of experimental systems representing different disease states, we found that the response of cells to multiple drugs is well described by a low order, rather smooth, drug-mixture-input/drug-effect-output multidimensional surface. The main consequences of this are that optimal drug combinations can be found in a surprisingly small number of tests, and that translation from in vitro to in vivo is simplified. This points to the possibility of personalized optimal drug mixtures in the near future. This unexpectedly simple input-output relationship may also lead to a simple solution for handling the issue of human diversity in cancer therapeutics.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25427213     DOI: 10.1088/1478-3975/11/6/065003

Source DB:  PubMed          Journal:  Phys Biol        ISSN: 1478-3967            Impact factor:   2.583


  8 in total

1.  Optimization of drug combinations using Feedback System Control.

Authors:  Patrycja Nowak-Sliwinska; Andrea Weiss; Xianting Ding; Paul J Dyson; Hubert van den Bergh; Arjan W Griffioen; Chih-Ming Ho
Journal:  Nat Protoc       Date:  2016-01-14       Impact factor: 13.491

Review 2.  Enabling Technologies for Personalized and Precision Medicine.

Authors:  Dean Ho; Stephen R Quake; Edward R B McCabe; Wee Joo Chng; Edward K Chow; Xianting Ding; Bruce D Gelb; Geoffrey S Ginsburg; Jason Hassenstab; Chih-Ming Ho; William C Mobley; Garry P Nolan; Steven T Rosen; Patrick Tan; Yun Yen; Ali Zarrinpar
Journal:  Trends Biotechnol       Date:  2020-01-21       Impact factor: 19.536

3.  Output-driven feedback system control platform optimizes combinatorial therapy of tuberculosis using a macrophage cell culture model.

Authors:  Aleidy Silva; Bai-Yu Lee; Daniel L Clemens; Theodore Kee; Xianting Ding; Chih-Ming Ho; Marcus A Horwitz
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-28       Impact factor: 11.205

4.  Drug regimens identified and optimized by output-driven platform markedly reduce tuberculosis treatment time.

Authors:  Bai-Yu Lee; Daniel L Clemens; Aleidy Silva; Barbara Jane Dillon; Saša Masleša-Galić; Susana Nava; Xianting Ding; Chih-Ming Ho; Marcus A Horwitz
Journal:  Nat Commun       Date:  2017-01-24       Impact factor: 14.919

5.  Cellular Signaling Analysis shows antiviral, ribavirin-mediated ribosomal signaling modulation.

Authors:  Xianting Ding; Peter O Krutzik; Amir Ali Ghaffari; Yixiu Zhaozhi; Daniel Miranda; Genhong Cheng; Chih-Ming Ho; Garry P Nolan; David Jesse Sanchez
Journal:  Antiviral Res       Date:  2019-09-09       Impact factor: 5.970

6.  Drug-Drug Interactions of Irinotecan, 5-Fluorouracil, Folinic Acid and Oxaliplatin and Its Activity in Colorectal Carcinoma Treatment.

Authors:  Marloes Zoetemelk; George M Ramzy; Magdalena Rausch; Patrycja Nowak-Sliwinska
Journal:  Molecules       Date:  2020-06-04       Impact factor: 4.411

7.  Colorectal Cancer Growth Retardation through Induction of Apoptosis, Using an Optimized Synergistic Cocktail of Axitinib, Erlotinib, and Dasatinib.

Authors:  Robert H Berndsen; Nathalie Swier; Judy R van Beijnum; Patrycja Nowak-Sliwinska
Journal:  Cancers (Basel)       Date:  2019-11-27       Impact factor: 6.639

8.  Identification of a Synergistic Multi-Drug Combination Active in Cancer Cells via the Prevention of Spindle Pole Clustering.

Authors:  Andrea Weiss; Morgan Le Roux-Bourdieu; Marloes Zoetemelk; George M Ramzy; Magdalena Rausch; Daniela Harry; Marijana Miljkovic-Licina; Katayoun Falamaki; Bernard Wehrle-Haller; Patrick Meraldi; Patrycja Nowak-Sliwinska
Journal:  Cancers (Basel)       Date:  2019-10-22       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.